Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.
Hernandez-Fuentes MP, Franklin C, Rebollo-Mesa I, Mollon J, Delaney F, Perucha E, Stapleton C, Borrows R, Byrne C, Cavalleri G, Clarke B, Clatworthy M, Feehally J, Fuggle S, Gagliano SA, Griffin S, Hammad A, Higgins R, Jardine A, Keogan M, Leach T, MacPhee I, Mark PB, Marsh J, Maxwell P, McKane W, McLean A, Newstead C, Augustine T, Phelan P, Powis S, Rowe P, Sheerin N, Solomon E, Stephens H, Thuraisingham R, Trembath R, Topham P, Vaughan R, Sacks SH, Conlon P, Opelz G, Soranzo N, Weale ME, Lord GM; United Kingdom and Ireland Renal Transplant Consortium (UKIRTC) and the Wellcome Trust Case Control Consortium (WTCCC)-3.
Hernandez-Fuentes MP, et al. Among authors: phelan p.
Am J Transplant. 2018 Jun;18(6):1370-1379. doi: 10.1111/ajt.14594. Epub 2018 Feb 1.
Am J Transplant. 2018.
PMID: 29392897
Free PMC article.
Improvements in immunosuppression have modified short-term survival of deceased-donor allografts, but not their rate of long-term failure. ...No strong donor or recipient genetic effects contributing to long- or short-term allograft survival were found outsid …
Improvements in immunosuppression have modified short-term survival of deceased-donor allografts, but not their rate of long-term …